These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1153 related articles for article (PubMed ID: 18802153)
1. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. Dieu-Nosjean MC; Antoine M; Danel C; Heudes D; Wislez M; Poulot V; Rabbe N; Laurans L; Tartour E; de Chaisemartin L; Lebecque S; Fridman WH; Cadranel J J Clin Oncol; 2008 Sep; 26(27):4410-7. PubMed ID: 18802153 [TBL] [Abstract][Full Text] [Related]
2. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885 [TBL] [Abstract][Full Text] [Related]
4. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer. Dai F; Liu L; Che G; Yu N; Pu Q; Zhang S; Ma J; Ma L; You Z BMC Cancer; 2010 May; 10():220. PubMed ID: 20487543 [TBL] [Abstract][Full Text] [Related]
5. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer. Xin S; Wen S; He P; Zhao Y; Zhao H Front Immunol; 2024; 15():1423775. PubMed ID: 39192984 [TBL] [Abstract][Full Text] [Related]
6. Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring. Berthe J; Poudel P; Segerer FJ; Jennings EC; Ng F; Surace M; Andoni A; Testori M; Saraiya M; Vuko M; Hessel H; Heininen-Brown M; Blando J; Jones EV; Willis SE; Galon J; van de Ven R; de Gruijl TD; Angell HK Front Immunol; 2024; 15():1422206. PubMed ID: 39376565 [TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040 [TBL] [Abstract][Full Text] [Related]
9. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade. Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341 [TBL] [Abstract][Full Text] [Related]
10. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
11. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer. Barua S; Fang P; Sharma A; Fujimoto J; Wistuba I; Rao AUK; Lin SH Lung Cancer; 2018 Mar; 117():73-79. PubMed ID: 29409671 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy. Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781 [TBL] [Abstract][Full Text] [Related]
13. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer. Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626 [TBL] [Abstract][Full Text] [Related]
16. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC. Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448 [TBL] [Abstract][Full Text] [Related]
18. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer. Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710 [TBL] [Abstract][Full Text] [Related]